@theeditorslist headlines the Daily Mail talking about Ozempic face
She landed the Daily Mail front page this week discussing Ozempic face and the steps she says she took to protect her own.
Recap by typeshit. Post by @theeditorslist on Instagram.
She landed the Daily Mail front page this week discussing Ozempic face and the steps she says she took to protect her own.
Recap by typeshit. Post by @theeditorslist on Instagram.
A Weird Science riff frames her before and after, crediting GLP-1 medication for taking her from 233 pounds down to 133.
The Post digs into how weight loss on GLP-1 drugs may be affecting marriages, and finds the answer is not simple.
She explains that GLP-1 drugs copy a hormone the body already makes, and says they can curb appetite, slow digestion and help with blood sugar.
Dr. Shah walks through how GLP-1s work, who stands to benefit, common side effects, and NorthShore's weight management clinic.
6:25
Dr Almerie compares Lilly's experimental retatrutide with Mounjaro and talks through the case for switching versus holding off until it's approved.
He says the woman's retatrutide came from neither Lilly nor a compounding pharmacy, and her liver failed within six days of starting it.
Loading…